Mutations in the Nucleotide Binding Domain 1 Signature Motif Region Rescue Processing and Functional Defects of Cystic Fibrosis Transmembrane Conductance Regulator ΔF508

The gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR), an ATP binding cassette (ABC) transporter that functions as a phosphorylation- and nucleotide-regulated chloride channel, is mutated in cystic fibrosis (CF) patients. Deletion of a phenylalanine at amino acid position 508 (ΔF508) in the first nucleotide binding domain (NBD1) is the most prevalent CF-causing mutation and results in defective protein processing and reduced CFTR function, leading to chloride impermeability in CF epithelia and heterologous systems. Using a STE6/CFTRΔF508 chimera system in yeast, we isolated two novel ΔF508 revertant mutations, I539T and G550E, proximal to and within the conserved ABC signature motif of NBD1, respectively. Western blot and functional analysis in mammalian cells indicate that mutations I539T and G550E each partially rescue the CFTRΔF508 defect. Furthermore, a combination of both revertant mutations resulted in a 38-fold increase in CFTRΔF508-mediated chloride current, representing 29% of wild type channel activity. The G550E mutation increased the sensitivity of CFTRΔF508 and wild type CFTR to activation by cAMP agonists and blocked the enhancement of CFTRΔF508 channel activity by 2 mm 3-isobutyl-1-methylxanthine. The data show that the ΔF508 defect can be significantly rescued by second-site mutations in the nucleotide binding domain 1 region, that includes the LSGGQ consensus motif. The gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR), an ATP binding cassette (ABC) transporter that functions as a phosphorylation- and nucleotide-regulated chloride channel, is mutated in cystic fibrosis (CF) patients. Deletion of a phenylalanine at amino acid position 508 (ΔF508) in the first nucleotide binding domain (NBD1) is the most prevalent CF-causing mutation and results in defective protein processing and reduced CFTR function, leading to chloride impermeability in CF epithelia and heterologous systems. Using a STE6/CFTRΔF508 chimera system in yeast, we isolated two novel ΔF508 revertant mutations, I539T and G550E, proximal to and within the conserved ABC signature motif of NBD1, respectively. Western blot and functional analysis in mammalian cells indicate that mutations I539T and G550E each partially rescue the CFTRΔF508 defect. Furthermore, a combination of both revertant mutations resulted in a 38-fold increase in CFTRΔF508-mediated chloride current, representing 29% of wild type channel activity. The G550E mutation increased the sensitivity of CFTRΔF508 and wild type CFTR to activation by cAMP agonists and blocked the enhancement of CFTRΔF508 channel activity by 2 mm 3-isobutyl-1-methylxanthine. The data show that the ΔF508 defect can be significantly rescued by second-site mutations in the nucleotide binding domain 1 region, that includes the LSGGQ consensus motif. cystic fibrosis CF transmembrane conductance regulator ATP binding cassette nucleotide binding domain CAMP-dependent protein kinase wild type Fischer rat thyroid 3-isobutyl-1-methylxanthine analysis of variance multidrug resistance-related protein Cystic fibrosis (CF)1 is the most frequent lethal genetic disease associated with a single gene in Caucasians (1Collins F.S. Science. 1992; 256: 774-779Crossref PubMed Scopus (735) Google Scholar). CF results from mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, which encodes an ATP binding cassette (ABC) transporter that functions as a phosphorylation and nucleotide-regulated chloride channel located in the apical membrane of epithelial cells (2Riordan J.R. Rommens J.M. Kerem B. Alon N. Rozmahel R. Grzelczak Z. Zielenski J. Lok S. Plavsic N. Chou J.L. Drumm M.L. Iannuzzi M.C. Collins F.S. Tsui L.C. Science. 1989; 245: 1066-1073Crossref PubMed Scopus (6181) Google Scholar, 3Sheppard D.N. Welsh M.J. Physiol. Rev. 1999; 79: S23-S45Crossref PubMed Scopus (824) Google Scholar). The ABC transporters constitute a large family of ubiquitously expressed proteins, mostly involved in ATP-driven translocation of diverse substrates across biological membranes (4Young J. Holland I.B. Biochim. Biophys. Acta. 1999; 1461: 177-200Crossref PubMed Scopus (136) Google Scholar, 5Higgins C.F. Annu. Rev. Cell Biol. 1992; 8: 67-113Crossref PubMed Scopus (3432) Google Scholar). It has been proposed that a functional ABC transporter has a minimal structural requirement of two membrane-spanning domains and two nucleotide binding domains (NBDs) (5Higgins C.F. Annu. Rev. Cell Biol. 1992; 8: 67-113Crossref PubMed Scopus (3432) Google Scholar). The NBDs, or ABC cassettes, share 30–50% sequence identity (6Hyde S.C. Emsley P. Hartshorn M.J. Mimmack M.M. Gileadi U. Pearce S.R. Gallagher M.P. Gill D.R. Hubbard R.E. Higgins C.F. Nature. 1990; 346: 362-365Crossref PubMed Scopus (1002) Google Scholar) and are characterized by the presence of three conserved motifs; Walker A and Walker B motifs are present in several nucleotide binding and hydrolyzing proteins (7Walker J.E. Saraste M. Runswick M.J. Gay N.J. EMBO J. 1982; 1: 945-951Crossref PubMed Scopus (4437) Google Scholar), and the ABC-signature motif, located just upstream of the Walker B, is diagnostic of ABC cassettes (5Higgins C.F. Annu. Rev. Cell Biol. 1992; 8: 67-113Crossref PubMed Scopus (3432) Google Scholar, 6Hyde S.C. Emsley P. Hartshorn M.J. Mimmack M.M. Gileadi U. Pearce S.R. Gallagher M.P. Gill D.R. Hubbard R.E. Higgins C.F. Nature. 1990; 346: 362-365Crossref PubMed Scopus (1002) Google Scholar). The deletion of the Phe-508 (ΔF508) in the first nucleotide binding domain (NBD1) of CFTR is the most frequent CF-causing mutation, present in 90% of CF chromosomes. ΔF508 impairs normal protein maturation and trafficking to the plasma membrane (8Cheng S.H. Gregory R.J. Marshall J. Paul S. Souza D.W. White G.A. O'Riordan C.R. Smith A.E. Cell. 1990; 63: 827-834Abstract Full Text PDF PubMed Scopus (1471) Google Scholar, 9Kartner N. Augustinas O. Jensen T.J. Naismith A.L. Riordan J.R. Nat. Genet. 1992; 1: 321-327Crossref PubMed Scopus (334) Google Scholar), presumably through a localized effect on the folding of the NBD1 domain (10Massiah M.A., Ko, Y.H. Pedersen P.L. Mildvan A.S. Biochemistry. 1999; 38: 7453-7461Crossref PubMed Scopus (19) Google Scholar, 11Thomas P.J., Ko, Y.H. Pedersen P.L. FEBS Lett. 1992; 312: 7-9Crossref PubMed Scopus (60) Google Scholar, 12Thomas P.J. Pedersen P.L. J. Bioenerg. Biomembr. 1993; 25: 11-19Crossref PubMed Scopus (33) Google Scholar). This misfolding results in retention of CFTRΔF508 by the endoplasmic reticulum-associated quality control and in subsequent degradation with the participation of the cytoplasmic proteasome (13Kopito R.R. Physiol. Rev. 1999; 79: PubMed Scopus Google Scholar). The CFTRΔF508 processing defect can be partially rescued by M.P. Marshall J. Smith A.E. Welsh M.J. Nature. 1992; PubMed Scopus Google Scholar), of S. R.R. J. Biol. Full Text Full Text PDF PubMed Scopus Google Scholar), and that the folding C.R. J. Bioenerg. Biomembr. PubMed Scopus Google Scholar). CFTR channel is by phosphorylation by protein kinase at in the domain and by ATP binding and at the D.N. Welsh M.J. Physiol. Rev. 1999; 79: S23-S45Crossref PubMed Scopus (824) Google Scholar, Physiol. Rev. 1999; 79: PubMed Scopus Google Scholar). phosphorylation of in the domain the channel and of CFTR by the of ATP M. M. Rommens J.M. J. Biol. Full Text Full Text PDF PubMed Scopus Google Scholar, M.C. Welsh M.J. Nature. PubMed Scopus Google Scholar). CFTR is in by of in with D.N. Welsh M.J. Physiol. Rev. 1999; 79: S23-S45Crossref PubMed Scopus (824) Google Scholar, Physiol. Rev. 1999; 79: PubMed Scopus Google Scholar, O. Welsh M.J. J. Biol. Full Text Full Text PDF PubMed Scopus Google Scholar). The ΔF508 mutation CFTR by the channel P. S. M. Nature. PubMed Scopus Google Scholar, S. J. Physiol. Scopus Google Scholar). The defective activity of CFTRΔF508 channel can be I.B. J. Physiol. PubMed Google Scholar, 1999; PubMed Scopus Google Scholar, J. Physiol. PubMed Google Scholar). in the NBD1 that are by we isolated mutations that rescued the functional and processing of of the sequence of of CFTR and the Nature. 1989; PubMed Scopus Google Scholar, R.E. J. EMBO J. 1989; 8: PubMed Scopus Google Scholar), a chimera to the ΔF508 mutation in J.L. Tsui L.C. Welsh M.J. Cell. 1993; Full Text PDF PubMed Scopus Google Scholar, J.L. Welsh M.J. Google Scholar). to ΔF508 the of ABC transporters J. PubMed Google Scholar, A.L. Collins F.S. Science. PubMed Scopus Google Scholar, Cell. Biol. 1999; PubMed Google Scholar, J. Biol. Full Text Full Text PDF PubMed Scopus Google Scholar, 25: PubMed Scopus Google Scholar). The mutation to ΔF508 in the gene, in a defective S. EMBO J. PubMed Scopus Google Scholar), in the of the CFTR ΔF508 the of chimera J.L. Tsui L.C. Welsh M.J. Cell. 1993; Full Text PDF PubMed Scopus Google Scholar, R. S. PubMed Scopus Google Scholar), a system of ΔF508 revertant mutations within CFTR we the chimera system to novel amino acid just upstream and within the ABC signature motif of CFTR NBD1 that partially the CFTRΔF508 defect in cells and in Fischer rat thyroid The G550E mutation a amino acid in the conserved LSGGQ signature motif of CFTR the of mutation is by two CF-causing mutations been that of CFTR or channel J. J. 1999; PubMed Scopus Google Scholar, J. J. 1999; PubMed Scopus Google Scholar, M. Rommens J.M. J. Biol. Full Text Full Text PDF PubMed Scopus Google Scholar, P.J. J. Biol. Full Text Full Text PDF PubMed Scopus Google Scholar, J. P. Z. J. B. J. PubMed Scopus Google Scholar). the effect of the G550E mutation on the activation of wild type and CFTR chloride the effect of two to CFTRΔF508 and 3-isobutyl-1-methylxanthine I.B. J. Physiol. PubMed Google Scholar, 1999; PubMed Scopus Google Scholar, J. Physiol. PubMed Google Scholar), on the ΔF508 revertant The of the of the and STE6/CFTRΔF508 in has been J.L. Tsui L.C. Welsh M.J. Cell. 1993; Full Text PDF PubMed Scopus Google Scholar). from the gene, is a single that the and the gene to amino acid by the from CFTR the CFTRΔF508 sequence to A of CFTRΔF508 by on the amino and on the by of the and mutations within Biochemistry. PubMed Scopus Google Scholar, D.W. 1989; 1: Scholar) at the position to CFTR in the to Nature. 1989; PubMed Scopus Google Scholar) with the and the the as a of R. U. S. PubMed Scopus Google Scholar). The cells in the gene, and with the The as J.L. Tsui L.C. Welsh M.J. Cell. 1993; Full Text PDF PubMed Scopus Google Scholar, J.L. Welsh M.J. Google Scholar). a of cells and to a and at to cells to a with a isolated from single that to and a cells with each to in each with an of cells and by a that on a at and from at and J. Cell. Biol. PubMed Scopus Google Scholar). the of CFTR in CFTR J.L. Tsui L.C. Welsh M.J. Cell. 1993; Full Text PDF PubMed Scopus Google Scholar) at and the Phe-508 to the from the by in the M. U. S. 1992; PubMed Scopus Google Scholar) The CFTR of the gene mutations by the and The and in a to CFTR nucleotide and and by cells at in a with with and and B The system O. B. U. S. 1989; PubMed Scopus Google Scholar) of the CFTR in as J.L. Tsui L.C. Welsh M.J. Cell. 1993; Full Text PDF PubMed Scopus Google Scholar). of cells with and with each CFTR the control of the and cells and CFTR and CFTR ΔF508 D.N. Welsh M.J. J. Physiol. Google Scholar) from of cells at in a of with and and B cells in a and and in of to cells to and in with each CFTR at 2 with and on chloride cells with CFTR and the to and CFTR chloride in analysis of CFTR cells with and with mm mm a mm 1 and cells and by proteins in the in and at on with in 2 of and in 1 mm 1 mm with mm 1 and a in the through a and and and the to The membranes in and at of protein by on to membranes CFTR with the which an within the CFTR N. Augustinas O. Jensen T.J. Naismith A.L. Riordan J.R. Nat. Genet. 1992; 1: 321-327Crossref PubMed Scopus (334) Google Scholar). A and protein CFTR or at on and in and with at chloride by the with a mm mm mm mm and mm and the apical with a that mm the mm the chloride to The the The to channel of of and by in to of 1 or The on a Western a within and to the apical as each and the current, the of chloride by as a The as the the and the of the or the by the of the and results expressed in are expressed as the by the or by with a at a or A gene in which a amino acid within NBD1 of to by the of the CFTR NBD1 to has been J.L. Tsui L.C. Welsh M.J. Cell. 1993; Full Text PDF PubMed Scopus Google Scholar). the mutation and the ΔF508 mutation in the CFTR of the by a reduced to of J.L. Tsui L.C. Welsh M.J. Cell. 1993; Full Text PDF PubMed Scopus Google Scholar). the ΔF508 mutation can be in yeast, system can be the of mutations within the CFTR NBD1 that to the mutations, the CFTR of to in and a to with an increased to a revertant rescued and to the by a associated with novel mutations isolated in the CFTR sequence that rescued the defect in the of of the CFTR sequence to a and of to at the position by the of of are expressed as of and the in a of are expressed as of and the The two novel ΔF508 revertant mutations isolated in located just upstream or within the CFTR NBD1 signature motif the three ΔF508 revertant mutations isolated the and are located within the NBD1 signature motif J.L. Tsui L.C. Welsh M.J. Cell. 1993; Full Text PDF PubMed Scopus Google Scholar, J.L. Welsh M.J. Google Scholar). the effect of the novel revertant mutations on CFTRΔF508 I539T and G550E mutations the CFTRΔF508 and in mammalian the combination of the I539T and G550E mutations in an or effect in the ΔF508 we a CFTRΔF508 both revertant mutations The CFTR expressed in cells a and the of CFTR protein in the by by Western analysis the endoplasmic of to as CFTR present as both B and The CFTR that to the processing that I539T to a G550E partially rescued the defect. The of protein with each revertant 2 I539T and G550E mutations partially rescue and functional the of CFTR protein from in cells with and with each CFTR Cell and protein by Western with cells with as the of the and CFTR are by the B, the CFTRΔF508 in at in and chloride activation with and The results are expressed as of chloride by CFTR the and the the of by and indicate the CFTR a increase in chloride CFTRΔF508 by chloride by CFTR as in B. by and indicate the CFTR a increase in chloride CFTR by we the chloride channel of the of CFTRΔF508 present in the at the plasma and wild type CFTR expressed in epithelial which are to with and a chloride channel D.N. Welsh M.J. J. Physiol. Google Scholar, O. Welsh M.J. J. Physiol. Cell. Physiol. PubMed Google Scholar). CFTR are by a and D.N. Welsh M.J. J. Physiol. Google Scholar). in and the chloride activation with and the of CFTR to chloride in to cAMP agonists D.N. Welsh M.J. J. Physiol. Google Scholar). cells with CFTR to cAMP agonists with a increase in increased chloride D.N. Welsh M.J. J. Physiol. Google Scholar). chloride in to of CFTR 2 The ΔF508 and and in chloride to 2 The combination of the two revertant mutations resulted in 29% of CFTR chloride representing a rescue of the chloride impermeability of epithelia the effect of the ΔF508 revertant mutations on CFTR chloride channel function, and a CFTR both I539T and G550E mutations expressed in and chloride activation with and The results in 2 indicate that chloride by and significantly from CFTR CFTR in 2 B, the G550E mutation I539T in the chloride channel of CFTRΔF508 of protein to 2 the G550E mutation in a conserved the consensus ABC signature motif from LSGGQ to The functional of the NBD1 signature motif is from the of the mutation which processing results in CFTR chloride channel J. P. Z. J. B. J. PubMed Scopus Google Scholar, J. PubMed Scopus Google Scholar) on chloride of CF-causing mutations and ΔF508 revertant mutations within the LSGGQ of CFTR cells the CFTR in and chloride as in 2 B. are expressed as of CFTR chloride and the the of The indicate the a increase in chloride CFTRΔF508 by in a cells the CFTR in and chloride as in 2 B. are expressed as of CFTR chloride and the the of The indicate the a increase in chloride CFTRΔF508 by the by which the G550E mutation the of we effect on activation of CFTRΔF508 and CFTR by of CFTR expressed in cells is with D.N. Welsh M.J. J. Physiol. Google Scholar), with in channel activity O. Welsh M.J. J. Physiol. Cell. Physiol. PubMed Google Scholar). CFTR and expressed in and the chloride in to activation by of in the of The results each expressed as the of chloride current, with the by activation of the with and The G550E mutation the sensitivity of CFTRΔF508 to the of chloride by the of from of activation CFTRΔF508 to CFTR the G550E mutation increase the chloride channel activity of CFTR the with the of cAMP agonists 2 we that G550E increase the sensitivity of CFTR to activation by the of of CFTR and CFTR G550E, and to the effect of the revertant mutations on CFTRΔF508 processing and and been D.N. Welsh M.J. J. Physiol. Google Scholar). from CFTR analysis and functional the of the CFTR ΔF508 processing and chloride impermeability by I539T and G550E mutations, as the A and a increase in chloride in to which is in with the of protein and the significantly and we of both and protein a increase in to ΔF508 the and the of B the revertant results that the G550E mutation the channel activity of CFTR the ΔF508 The defect can be partially by mammalian cells at M.P. Marshall J. Smith A.E. Welsh M.J. Nature. 1992; PubMed Scopus Google Scholar) or by the in cells that are at as cells M. Jensen Rommens J.M. Nat. Genet. 1993; PubMed Scopus Google Scholar) and M.L. Collins F.S. Science. PubMed Scopus Google Scholar). the effect of the revertant mutations I539T and G550E on the sensitivity of CFTR the rescue of CFTRΔF508 by and the effect of the revertant mutations on the sensitivity of each CFTR at by a at which at of ΔF508 resulted in increase in with the results by M.P. Marshall J. Smith A.E. Welsh M.J. Nature. 1992; PubMed Scopus Google Scholar, M. C.R. J. Physiol. Cell Physiol. PubMed Google Scholar), we an increase in chloride CFTR The G550E mutation the sensitivity of as the resulted in a increase in chloride The I539T mutation CFTRΔF508 and to at The of with the of at The increase in sensitivity to activation the in we to be an of the is that the sensitivity to activation is to a the increased of at the plasma membrane J. Physiol. PubMed Scopus Google Scholar). the effect of G550E and I539T on the of sensitivity of CFTRΔF508 to activation the effect of channel at the plasma we the sensitivity to activation of CFTR ΔF508 rescued by at with and at each CFTR in and the chloride in to of The results are expressed as the of by activation with and each The results that CFTR the G550E mutation increased sensitivity to activation at with CFTRΔF508 we a increase in sensitivity to activation by the results from both I539T and a increase in sensitivity to activation to the of in to the G550E, increased sensitivity to activation by of cAMP the I539T we the activation of CFTR and expressed in CFTR and in and with of The expressed as the of by activation with and The activation by a increase in sensitivity to CFTR the the results with the The rescue of the ΔF508 defect by the G550E mutation to ΔF508 revertant mutations at revertant of the ΔF508 by the the G550E mutation a with the we a to the from an a effect on CFTR channel The effect of mutations at position on chloride channel of CFTRΔF508 by of each expressed as the of CFTR CFTR CF-causing mutations within the NBD1 signature motif, and in the and as A increase each novel ΔF508 revertant at position to CFTRΔF508 and and of that as as G550E in the CFTR ΔF508 defect. the to activation by of as in the results to been isolated that channel activity of CFTR by that are of increase in cAMP Z. S. J. Physiol. PubMed Google Scholar, D.N. 1999; Full Text Full Text PDF PubMed Scopus Google Scholar). The effect of the G550E mutation to increased sensitivity to activation of and CFTR to mutation the of CFTRΔF508 to by two the effect of 2 mm and on the activity of and CFTR the CFTR at and of are to the channel activity of of CFTR present at the plasma membrane J. Physiol. PubMed Google Scholar). a activity of wild type and CFTR in several S. J. Physiol. Scopus Google Scholar, 1999; PubMed Scopus Google Scholar, J. Physiol. PubMed Google Scholar, Z. S. J. Physiol. PubMed Google Scholar, J. PubMed Scopus Google Scholar). of been to be B. Fischer J. Physiol. PubMed Google M. J. Physiol. Google Scholar). to the apical of in and the with a and we channel activation by of the significantly increased the the the ΔF508 mutation, a increase the G550E and increase CFTRΔF508 and with and and enhancement of chloride by the present at the has been to an effect on CFTRΔF508 activity that is from activity as a I.B. J. Physiol. PubMed Google Scholar, 1999; PubMed Scopus Google Scholar, Z. S. J. Physiol. PubMed Google Scholar, R.J. J. Biol. 1999; PubMed Scopus Google Scholar). the CFTR in and with and 2 resulted in increase and 2 mm the of the or the novel ΔF508 revertant mutations just upstream and within the consensus ABC signature motif LSGGQ in the NBD1 of mutation partially processing of CFTRΔF508 expressed in with I539T the most chloride in and to and respectively. The of and to functional localized at the plasma Furthermore, functional a revertant that I539T and G550E mutations to increase CFTRΔF508 chloride to of CFTR representing a 38-fold increase the CF of as by the of the processing defect of CFTRΔF508 rescued by second-site mutations in the of the LSGGQ motif of NBD1, leading to increased functional activity of at the plasma The I539T and G550E mutations as of the CF-causing mutation It be that revertant mutations, by of to the ΔF508 be of results by that G550E can partially rescue CF Scholar). the ΔF508 and mutations misfolding in a each to be partially by the a effect to increase CFTR of the that the combination of I539T and G550E within wild type CFTR increased functional activity. be to the to which ΔF508 revertant mutations I539T and G550E CF mutations within the NBD1 that are associated with defective protein the of the revertant mutations on we the functional activity of and ΔF508 is a mutation M.P. Marshall J. Smith A.E. Welsh M.J. Nature. 1992; PubMed Scopus Google Scholar), we revertant mutations the sensitivity of The I539T mutation, in CFTRΔF508 or to It is that the I539T revertant mutation and the the in the protein folding are The of CFTRΔF508 by mutations has been by Jensen T.J. Riordan J.R. Cell. 1999; Full Text Full Text PDF PubMed Scopus Google Scholar). to G550E effect on CFTRΔF508 that the protein folding to the processing the ΔF508 mutation impairs the chloride channel of The of CFTRΔF508 is to CFTR P. S. M. Nature. PubMed Scopus Google Scholar, I.B. J. Physiol. PubMed Google Scholar) to which are CFTR by of J. Physiol. PubMed Google Scholar). from cells CFTR and CFTR ΔF508 indicate that the ΔF508 mutation CFTR activation by phosphorylation S. J. Physiol. Scopus Google Scholar). results show that the G550E mutation the of of the CFTR CFTR and Furthermore, G550E mutation activity of CFTR the ΔF508 mutation and and the wild type channel activity of activity that mutation increase of G550E CFTR phosphorylation activity. the of G550E in CFTR phosphorylation to be the effect of G550E to increase the activity of CFTRΔF508 is with the of associated with to the of protein and are to the functional activity of CFTRΔF508 I.B. J. Physiol. PubMed Google Scholar, 1999; PubMed Scopus Google Scholar, J. Physiol. PubMed Google Scholar), we the effect of on and results show that 2 mm an increase in chloride the effect of on has been that 2 mm activity of the CFTRΔF508 channel with increase in cAMP Z. S. J. Physiol. PubMed Google Scholar). effect of on CFTR which is with functional M.L. Collins F.S. Science. PubMed Scopus Google Scholar) and with the that has a NBD1 ΔF508 to NBD1 Z. Biochemistry. PubMed Scopus Google Scholar). The effect of 2 mm on the activation of to the effect 2 mm increase the of or that G550E the binding of to the increase in or to the of 1999; PubMed Scopus Google Scholar). significantly chloride of and the by CFTR the G550E mutation to a It has been that increased the from cells CFTRΔF508 activation with a of increased CFTR the by of J. Physiol. PubMed Google Scholar). has been to CFTR Z. D.N. Scopus Google Scholar) and to increase in CFTRΔF508 S. J. Physiol. Scopus Google Scholar). The revertant mutations I539T and G550E enhancement of the activity of CFTRΔF508 to the CF the be at activity. I539T significantly the processing of is the most conserved amino acid at position CFTR of most as as ABC of the A of CFTRΔF508 chloride channel activity and a of protein been the ΔF508 CF R. S.H. J.R. M.J. Nat. Genet. PubMed Scopus Google Scholar, P.J. C.R. J. J. PubMed Scopus Google Scholar, M.J. J. Physiol. Cell Physiol. Google Scholar, P.J. J. EMBO J. PubMed Scopus Google Scholar). results that the to the defect by the ΔF508 mutation in the is a conserved within the ABC signature motif of several ABC with to CFTR The G550E mutation a of a the LSGGQ consensus signature sequence of NBD1 to is the signature motif in of the ABC A of Biophys. PubMed Scopus Google Scholar) and of and and The conserved signature motif an in the of ABC to motif of to translocation (6Hyde S.C. Emsley P. Hartshorn M.J. Mimmack M.M. Gileadi U. Pearce S.R. Gallagher M.P. Gill D.R. Hubbard R.E. Higgins C.F. Nature. 1990; 346: 362-365Crossref PubMed Scopus (1002) Google Scholar, S. J. Biol. Full Text Full Text PDF PubMed Scopus (33) Google Scholar), activation of ATP binding to of the transporter S. J. 1999; PubMed Scopus Google Scholar), and of J.M. M. J. M.J. P. J. PubMed Scopus Google Scholar, R. Genet. PubMed Scopus Google Scholar). participation of the ABC signature motif in the of has been Science. PubMed Scopus Google Scholar, Cell. Full Text Full Text PDF PubMed Scopus Google Scholar, Lett. 1999; PubMed Google Scholar). The CF-causing mutation of the in the NBD1 signature motif of CFTR has been to ATP binding J. P. Z. J. B. J. PubMed Scopus Google Scholar, R. Biophys. PubMed Scopus Google Scholar) and M. M. Rommens J.M. J. Biol. Full Text Full Text PDF PubMed Scopus Google Scholar). several ABC cassettes Science. PubMed Scopus Google Scholar, S.H. Nature. PubMed Scopus Google Scholar) a an ATP binding by the Walker A and Walker B motifs and a the ABC signature motif and upstream to the CFTR NBD1 that includes the Phe-508 and the revertant mutations are localized to the The position of LSGGQ in the ABC cassette is in with the proposed in the of the domains with involved in or I.B. J. Biol. 1999; PubMed Scopus Google Scholar). that G550E and I539T mutations the by the ΔF508 The functional of the LSGGQ of CFTR NBD1 has been by analysis processing and functional associated with amino acid in the conserved motif J. J. 1999; PubMed Scopus Google Scholar, J. J. 1999; PubMed Scopus Google Scholar, M. Rommens J.M. J. Biol. Full Text Full Text PDF PubMed Scopus Google Scholar, P.J. J. Biol. Full Text Full Text PDF PubMed Scopus Google Scholar, J. P. Z. J. B. J. PubMed Scopus Google Scholar). results indicate that mutations in CFTR ΔF508 processing and and the of the LSGGQ motif as a the defect associated with of the of the LSGGQ motif to the associated with ΔF508 be in the of participation in the and of Welsh the cells and CFTR and on the